SCHEMBL8511527

SCHEMBL8511527

CCCCNc1ccc(-c2ccc([O])cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
SCN5A Q14524 2/20 0.43
HRH3 Q9Y5N1 2/20 0.43
CYP1A2 P05177 1/20 0.43
MAOA P21397 1/20 0.43
CNR1 P21554 1/20 0.43
DRD4 P21917 1/20 0.43
ACHE P22303 1/20 0.43
HRH2 P25021 1/20 0.43
HTR2A P28223 1/20 0.43
HTR2C P28335 1/20 0.43
MAPK1 P28482 1/20 0.43
NTSR1 P30989 1/20 0.43
HRH1 P35367 1/20 0.43
DRD3 P35462 1/20 0.43
SCN1A P35498 1/20 0.43
HTR2B P41595 1/20 0.43
SCN7A Q01118 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KCNH2 Q12809 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30800856 0.90 MAPT (0.46) LMNASCN5AHRH3CYP1A2MAOA
SCHEMBL16101578 0.84 HRH3 (0.53) LMNASCN5AHRH3CYP1A2MAOA
SCHEMBL181559 0.83 MAPT (0.52) LMNASCN5AHRH3CYP1A2MAOA
SCHEMBL8972279 0.82 ALDH1A1 (0.56) LMNAACHERAB9AMAPTALDH1A1
SCHEMBL2494993 0.82 MAPT (0.61) LMNASCN5AHRH3CYP1A2MAOA
SCHEMBL4975464 0.81 MAPT (0.46) LMNAGAAMAPTALDH1A1AR
SCHEMBL8514565 0.81 APP (0.50) LMNASCN5AHRH3CYP1A2MAOA
SCHEMBL19035328 0.78 ALDH1A1 (0.41) LMNASCN5AHRH3CYP1A2MAOA
SCHEMBL17040408 0.78 RARB (0.51) LMNAHRH3ACHEHTR2AHTR2C
SCHEMBL20692502 0.77 MAPT (0.59) HRH3GAAABL1HRH4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2841471-B1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSTS GRACE W R & CO (US) 2020-05-06 EP disclosed
US-20190153135-A1 Activator Compositions, Their Preparation, And Their Use In Catalysts GRACE W R & CO (US) 2019-05-23 US disclosed
US-10221264-B2 Activator compositions, their preparation, and their use in catalysts W. R. GRACE & CO.-CONN. (US) 2019-03-05 US disclosed
CN-104854150-A Activator compositions, their preparation, and their use in catalysts ALBEMARLE CORP 2015-08-19 CN disclosed
US-20150105238-A1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSTS W. R. GRACE & CO.-CONN. 2015-04-16 US disclosed
EP-2643366-B1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSIS ALBEMARLE CORP (US) 2015-03-25 EP disclosed
EP-2841471-A1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSTS Albemarle Corporation (US) 2015-03-04 EP disclosed
US-8895465-B2 Activator compositions, their preparation, and their use in catalysis ALBEMARLE CORPORATION (US) 2014-11-25 US disclosed
WO-2013162745-A1 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSTS ALBEMARLE CORPORATION (US) 2013-10-31 WO disclosed
EP-2643366-A2 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSIS Albemarle Corporation (US) 2013-10-02 EP disclosed
US-20130253155-A1 Activator Compositions, Their Preparation, and Their Use In Catalysis ALBEMARIE CORPORATION (US) 2013-09-26 US disclosed
WO-2012071205-A2 ACTIVATOR COMPOSITIONS, THEIR PREPARATION, AND THEIR USE IN CATALYSIS ALBEMARLE CORPORATION (US) 2012-05-31 WO disclosed